Cellular Bone Matrices Reconsidered: Immunogenicity, Experimental and Clinical Evidence of Enhanced Effectiveness, Safety, and Value Proposition.

J Bone Joint Surg Am · Jun 18 2026 · Recent

Marino JF

General Orthopaedics

SUMMARY — THE REDUCTIONReview reconsidering the immunogenicity, efficacy, safety, and cost-value profile of cellular bone matrices used in orthopaedic reconstruction.

Featured in the 2026-06-21 issue.

← Perioperative Pain Management in Patients Being Treated for O…The Strength of the Splint: A Lesson in Buddy Taping. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.